研究目的：本研究旨在探討HPH的A、B、D三類量尺的臨床效度。研究方法：自2008／9／30至2009／8／31，本研究共募集了94位精神分裂症患者，60位罹患第一型雙極性疾患者，154位罹患憂鬱症（含重鬱症與輕鬱症）者，84位罹患焦慮性疾患者，以及207位學校及社區對照組。本研究收集這些受試在HPH的A、B、D三類量尺的作答反應。研究結果：本研究以392名臨床患者的反應，分別對A、B、D三類量尺進行因素分析，結果顯示大部分的因素內涵可符合HPH原先的編製理念。經由變異數分析及羅吉斯迴歸的結果顯示，HPH的A、B、D類量尺於區分心理健康與否上，是具有效度的。精神分裂症傾向因素可以有效地區分精神分裂症疾患與其他三組疾患的差異，躁症傾向因素可以有效地區辨第一型雙極性疾患與憂鬱疾患，而鬱症傾向因素可以有效地區辨憂鬱疾患與焦慮型疾患。研究結論：整體而言，本研究的結果支持HPH具有不錯的臨床效度。

Purpose: The goal of this study was to examine the clinical validity of the A, B, and D scales of the Health, Personality, and Habit Test (HPH). Methods: A total of 94 patients with schizophrenia, 60 patients with bipolar I disorder, 154 patients with depressive disorder (including major depression or dysthymia), 84 patients with anxiety disorder, and 207 normal control adults completed the A, B, and D scales of the HPH from 2008/9/30 to 2009/8/31. Results: Exploratory factor analysis of the 392 valid responses obtained from the patient sample indicated that the A, B, and D scales were mostly consistent with the original scale concepts. Findings from the ANOVA and logistic regression analysis indicated good validity for the A, B and D scales in that they could distinguish between individuals with psychopathology and the normal controls. The schizophrenic subscale discriminated schizophrenia from the other 3 types of mental disorders. The manic subscale differentiated bipolar I disorder and depressive disorder. The depressive subscale distinguished between depressive disorder and anxiety disorder. Conclusions: In general, the results of the current study supported the clinical validity of the HPH.